1. Home
  2. ALTI vs VNDA Comparison

ALTI vs VNDA Comparison

Compare ALTI & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$4.32

Market Cap

394.0M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.06

Market Cap

441.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
VNDA
Founded
2020
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.0M
441.5M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
ALTI
VNDA
Price
$4.32
$8.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$13.63
AVG Volume (30 Days)
159.7K
2.7M
Earning Date
03-12-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$226,717,000.00
$212,074,000.00
Revenue This Year
$19.78
$12.01
Revenue Next Year
$7.00
$24.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.12
52 Week Low
$2.33
$3.81
52 Week High
$5.45
$9.60

Technical Indicators

Market Signals
Indicator
ALTI
VNDA
Relative Strength Index (RSI) 48.66 60.82
Support Level $3.95 $7.14
Resistance Level $4.45 $7.82
Average True Range (ATR) 0.35 0.41
MACD -0.01 -0.04
Stochastic Oscillator 36.89 67.60

Price Performance

Historical Comparison
ALTI
VNDA

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: